Sep 2026· Cancer Research Communications· Vol 6, pp. 2232 - 2241· 0 citations· 38 references
Medicine
TL;DR
It is demonstrated that rare germline TE insertions in cancer predisposition genes can have functional consequences at the RNA level, and incorporating TE detection into genomic workflows may improve identification of cancer predisposition syndromes and expand understanding of noncoding contributions to pediatric cancer susceptibility.
Abstract
Abstract At least 10 to 15% of children with cancer have a pathogenic germline variant in a cancer predisposition gene. Studies of germline cancer predisposition, however, have focused primarily on single-nucleotide and copy-number variants, leaving other classes such as transposable elements (TE) largely unexplored. Although rare pathogenic TE insertions have been implicated in inherited cancer, their contribution to pediatric cancer predisposition remains unknown, partly because these repetitive sequences often require whole-genome sequencing (WGS) for detection. We characterized the germline TE insertion landscape using nontumor WGS data from 2,334 patients with pediatric cancer and 3,447 controls. Across 5,781 genomes, we identified 96,484 TE insertions, most of which were rare and located in intergenic or intronic regions. Whereas global TE burden did not differ between cases and controls, rare TE insertions were significantly enriched in cancer genes in patients with solid tumors, particularly within 3′ untranslated regions (P < 0.02). Gene–phenotype concordance analysis identified 19 insertions in genes with established dominant cancer predisposition, representing ∼0.8% of cases. Integration of RNA sequencing data revealed transcriptional impact for a subset of insertions. Notably, a 3′ untranslated region LINE-1 insertion in the tumor-suppressor gene PTEN disrupted alternative polyadenylation, whereas an SVA insertion in a STIM1 intron induced exonization, generating a novel transcript containing SVA sequence. These findings demonstrate that rare germline TE insertions in cancer predisposition genes can have functional consequences at the RNA level. Incorporating TE detection into genomic workflows may improve identification of cancer predisposition syndromes and expand understanding of noncoding contributions to pediatric cancer susceptibility. Significance: At least 10 to 15% of children with cancer have a germline predisposition; however, the true prevalence is likely higher. This study demonstrates that TE insertions can disrupt cancer predisposition genes and have functional consequences. Incorporating TE detection can identify cancer predisposition in children for whom standard testing is uninformative.
Although a heritable component is implicated in ~10% of melanomas, the prevalence and functional relevance of germline pathogenic variants (gPVs) in unselected patients remains unknown. We evaluated 701 patients with melanoma who underwent tumor-normal MSK-IMPACT sequencing (2015–2023) and germline analysis of ≥76 ca...
S. Lochrin, H. Walch, Y. Kemel et al.· npj Genomic Medicine· 0 citations
High-coverage whole-genome sequencing, large-scale transcriptomics, and eQTL are used to map male cancer cell lines, revealing a region-specific LOY landscape with recurrent euchromatic deletions affecting protein-coding genes and non-coding elements and motivating validation in primary tumor cohorts.
Trini Nguyen, Aditi Kuchi, Hong-Yu Liu et al.· Communications Biology· 0 citations
These findings provide the first characterization of putative PVs in feline candidate cancer-predisposing genes, representing an important step toward genomics-informed oncology and risk stratification in cats.
It is demonstrated that somatic rather than germline risk predominates in middle-aged healthy adults and the VAF-haplotype-sharing analysis framework provides a scalable framework for variant classification in large-scale population genomics.
H. A. MacGregor, J. Blundell, D. Easton· medRxiv· 0 citations
While pathogenic germline CHEK2 variants are known to increase cancer risk, there is currently insufficient evidence regarding the precise risk of developing malignant neoplasms associated with specific missense variants or variants of uncertain significance. As a result, no clear clinical guidelines exist regarding co...
M. Nemtsova, M. Makarova, Anastasiia M. Danishevich et al.· International Journal of Mol...· 0 citations
Functional evidence is provided to fine-tune the classification of these SAMD9L variants and significantly advance the understanding of the molecular mechanisms by which SAMD9L variants drive inherited myeloid neoplasms.
E. Vuelta, A. Liquori, M. Morín et al.· British Journal of Haematolo...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.